The Amtrak derailment in Philadelphia that left six people dead and dozens more injured has already prompted calls for increased infrastructure spending. "This one is a wake-up call," New York City Mayor Bill de Blasio said Wednesday on MSNBC’s Morning Joe. "We have got to get serious about investing in infrastructure."
There have been other wake-up calls before, and the dire need for infrastructure renewal isn’t news. Yet, as Politico’s Kathryn A. Wolfe reported, the deadly crash occurred just as a House panel was set to mark up a bill that would cut Amtrak’s funding for 2016 to $1.13 billion, or about $250 million less than the railroad service typically gets. (To be fair, it’s also not clear at this point what caused the horrific Amtrak derailment and whether infrastructure problems played a part or not — and the number of rail accidents each year has actually fallen significantly since 2006, according to Federal Railroad Administration data.)
Even before the Amtrak tragedy, though, de Blasio and Oklahoma City Mayor Mick Cornett, a Republican, along with some two dozen other mayors were scheduled to travel to Washington, D.C. today to press Congress for a long-term renewal of the federal transportation authorization bill. The current funding law is set to expire May 31.
Pretty much everyone agrees that it’s well past time for the country to repair and rebuild its dangerously dated bridges, roads, railways, water mains and other critical infrastructure. The hold-up has always been over how to fund it.
Here’s one suggestion: The U.S. has spent some $110 billion on rebuilding Afghanistan, including billions that can’t be accounted for or that the inspector general has found have been wasted. That’s a drop in the bucket compared to the trillions in domestic infrastructure spending that some have called for. Still, clamping down on that waste in Afghanistan, and on other money being frittered away, might allow for some spending to be redirected to other necessary and more productive needs, like domestic infrastructure.
That’s not to suggest we must entirely abandon nation building abroad in order to rebuild this country. It’s just to point out that Congress should be able to find the money to address our national priorities, something it has miserably failed to do of late.
There were 18 million military veterans in the United States in 2018, according to the Census Bureau. That figure includes 485,000 World War II vets, 1.3 million who served in the Korean War, 6.4 million from the Vietnam War era, 3.8 million from the first Gulf War and another 3.8 million since 9/11. We join with the rest of the country today in thanking them for their service.
Democratic presidential candidates are proposing a variety of new taxes to pay for their preferred social programs. Bloomberg’s Laura Davison and Misyrlena Egkolfopoulou took a look at how the top four candidates would fare under their own tax proposals.
“The fact is very little medical care is shoppable. We become good shoppers when we are repeat shoppers. If you buy a new car every three years, you can become an informed shopper. There is no way to become an informed shopper for your appendix. You only get your appendix out once.”
— David Newman, former director of the Health Care Cost Institute, quoted in an article Thursday by Noam Levey of the Los Angeles Times. Levey says the “consumer revolution” in health care – in which patients shop around for the best prices, forcing doctors, hospitals and pharmaceutical firms to compete with lower prices – hasn’t materialized, but the higher deductibles that were part of the effort are very much in effect. “High-deductible health insurance was supposed to make American patients into smart shoppers,” Levey writes. “Instead, they got stuck with medical bills they can't afford.”
The House Ways and Means Committee released a new analysis of drug prices in the U.S. compared to 11 other developed nations, and the results, though predictable, aren’t pretty. Here are the key findings from the report:
- The U.S. pays the most for drugs, though prices varied widely.
- U.S. drug prices were nearly four times higher than average prices compared to similar countries.
- U.S. consumers pay significantly more for drugs than other countries, even when accounting for rebates.
- The U.S. could save $49 billion annually on Medicare Part D alone by using average drug prices for comparator countries.